AU569161B2 - 4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives - Google Patents

4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives

Info

Publication number
AU569161B2
AU569161B2 AU43967/85A AU4396785A AU569161B2 AU 569161 B2 AU569161 B2 AU 569161B2 AU 43967/85 A AU43967/85 A AU 43967/85A AU 4396785 A AU4396785 A AU 4396785A AU 569161 B2 AU569161 B2 AU 569161B2
Authority
AU
Australia
Prior art keywords
group
compound
same
different
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43967/85A
Other languages
English (en)
Other versions
AU4396785A (en
Inventor
Masaharu Asano
Takashi Fujikura
Yasuo Isomura
Noriki Ito
Yuzo Matsumoto
Toichi Takenaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU4396785A publication Critical patent/AU4396785A/en
Application granted granted Critical
Publication of AU569161B2 publication Critical patent/AU569161B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU43967/85A 1984-06-28 1985-06-21 4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives Ceased AU569161B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59133650A JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法
JP59-133650 1984-06-28

Publications (2)

Publication Number Publication Date
AU4396785A AU4396785A (en) 1986-01-02
AU569161B2 true AU569161B2 (en) 1988-01-21

Family

ID=15109748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43967/85A Ceased AU569161B2 (en) 1984-06-28 1985-06-21 4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives

Country Status (13)

Country Link
US (1) US4727082A (enExample)
EP (1) EP0167371B1 (enExample)
JP (1) JPS6112662A (enExample)
KR (1) KR900005019B1 (enExample)
AT (1) ATE61356T1 (enExample)
AU (1) AU569161B2 (enExample)
CA (2) CA1300157C (enExample)
DE (1) DE3581967D1 (enExample)
ES (3) ES8707933A1 (enExample)
GR (1) GR851568B (enExample)
MX (2) MX7533E (enExample)
PT (1) PT80714B (enExample)
SU (1) SU1342413A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
CA1312611C (en) * 1987-07-01 1993-01-12 Yamanouchi Pharmaceutical Co., Ltd. Pyridine derivatives, process for production thereof and pharmaceutical composition containing them
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088274A1 (de) * 1982-03-05 1983-09-14 Bayer Ag Neue 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihrer Verwendung in Arzneimitteln

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2753946A1 (de) * 1977-12-03 1979-06-13 Bayer Ag 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088274A1 (de) * 1982-03-05 1983-09-14 Bayer Ag Neue 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihrer Verwendung in Arzneimitteln

Also Published As

Publication number Publication date
ES8704898A1 (es) 1987-04-16
EP0167371A3 (en) 1987-06-16
ES8707933A1 (es) 1987-09-01
ATE61356T1 (de) 1991-03-15
CA1300157C (en) 1992-05-05
JPH0123463B2 (enExample) 1989-05-02
PT80714B (en) 1986-12-11
JPS6112662A (ja) 1986-01-21
ES552336A0 (es) 1987-04-16
SU1342413A3 (ru) 1987-09-30
KR860000261A (ko) 1986-01-27
US4727082A (en) 1988-02-23
ES8704899A1 (es) 1987-04-16
DE3581967D1 (de) 1991-04-11
MX7533E (es) 1989-08-15
CA1312085C (en) 1992-12-29
EP0167371A2 (en) 1986-01-08
EP0167371B1 (en) 1991-03-06
ES552335A0 (es) 1987-04-16
PT80714A (en) 1985-07-01
GR851568B (enExample) 1985-11-25
AU4396785A (en) 1986-01-02
MX26687A (es) 1994-03-31
ES544647A0 (es) 1987-09-01
KR900005019B1 (ko) 1990-07-18

Similar Documents

Publication Publication Date Title
IL135180A0 (en) Sulfonyl derivatives
EP0902007A4 (en) CHALCONE DERIVATIVES AND MEDICINES CONTAINING THEM
HUP0301083A2 (hu) Szinergetikus hatású herbicid kompozíció és alkalmazása
KR880007471A (ko) 살균제 피리딜 이미데이트와 이를 이용한 살균제 조성물 및 억제방법
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
EP0104690A3 (en) Fungicidally active compositions containing ethene derivatives
AU4396785A (en) 4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives
EA199800150A1 (ru) Синергетическая фунгицидная композиция, содержащая соединение-аналог стробилурина
ES2091489T3 (es) Derivados de imidazol y composiciones farmaceuticas que los contienen.
WO1996023771A3 (en) Platelet aggregation inhibitors
RU95121070A (ru) Производные 1-алкил-3,5-диацил-1,4-дигидропиридина, смесь их изомеров или отдельные изомеры и фармацевтическая композиция с избирательным модулирующим действием на калиевые канальцы
KR880002828A (ko) 디하이드로피리딘 유도체 및 이것의 약학적 조성말
KR910004545A (ko) 신규 아조페닐 화합물,이를 함유한 조성물, 이에 제조방법 및 살균제로서 이들의 이용
AU557533B2 (en) Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives
IL92646A0 (en) Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
RU94043812A (ru) Производные 1,4-дигидропиридина, смесь их изомеров или отдельные изомеры и их соли, 2-хлор-3-циано-бензальдегид и фармацевтическая композиция
EP0330470A3 (en) 1,4-dihydropyridine derivatives useful against tumour cells
CA2064322A1 (en) Cyanoketone derivative and herbicide containing it as an active component
IL80402A0 (en) Dihydropyridines and pharmaceutical compositions containing them
WO2001019185A3 (en) Methods for controlling a pest population
AU2639388A (en) 2-cyano-2-aryl-1-(azole-1-yl)- ethane derivatives
RU93053026A (ru) N-ацетонилбензамиды и их использование в качестве фунгицидов
EP0136729A3 (en) Pesticidal benzoylurea derivatives